Amit Verma

Dr. Amit Verma


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2026 in Computation
Verified
Journal Article
Open access
PDF file
JAJose L. Agraz
Jose L. Agraz
AVAmit Verma
Amit Verma
CAClaudia Maricusa Agraz
Claudia Maricusa Agraz
The fields of medical diagnostics, nephrology, and the sequencing of cellular genetic material are pivotal for precise quantification of kidney diseases. Single-cell sequencing, enhanced by automation and software tools, enables efficient examination of biopsies at the individual cell level. This approach shows the complex cellular mosaic that shapes organ function. By quantifying gene expression following injury, single-cell analysis provides insight into disease progression. In this review, new developments in single-cell analysis methods, spatial integration of single-cell analysis, single-nucleus RNA sequencing, and emerging methods, including expression quantitative trait loci, whole-genome sequencing, and whole-exome sequencing in nephrology, are discussed. These advancements are poised to enhance kidney disease diagnostic processes, therapeutic strategies, and patient prognosis.

29 January 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
SKSalman Khan
Salman Khan
AZAlmaz Zaki
Almaz Zaki
MMMohammad Masood
Mohammad Masood
AKAman Khan
Aman Khan
MMMohd Mohsin
Mohd Mohsin
mansoor syedmansoor syed
mansoor syed

3 February 2026 in Trends in Immunotherapy
Verified
Journal Article
Open access
HAHaider Ali
Haider Ali
TUTilekeeva Um
Tilekeeva Um
DSDharmsheel Shrivastav
Dharmsheel Shrivastav
MBMirza Masroor Ali Beg
Mirza Masroor Ali Beg
VSVarun Kumar Sharma
Varun Kumar Sharma
AVAmit Verma
Amit Verma
Long non-coding RNAs (lncRNAs) have emerged as key regulators of gene expression involved in tumor initiation, progression, and metastasis. Among them, HOTAIR (HOX Transcript Antisense Intergenic RNA) and MALAT1 (Metastasis-Associated Lung Adenocarcinoma Transcript 1) have been implicated in several cancers, including breast cancer. However, their stage-specific expression patterns and prognostic relevance in breast cancer remain underexplored. This study aimed to evaluate the differential expression of HOTAIR and MALAT1 in early-stage (I–II) and late-stage (III–IV) breast cancers and to assess their association with clinicopathological and demographic parameters to determine their potential as prognostic biomarkers. Eighty breast cancer samples were analyzed for HOTAIR and MALAT1 expression using qRT-PCR. Clinicopathological data, including age, menopausal status, lymph node involvement, and hormone receptor status (ER, PR, HER2/neu), were collected. Logistic regression, ROC curve, and univariate analyses assessed their diagnostic and predictive significance. HOTAIR expression was significantly upregulated in late-stage (III–IV) breast cancer compared with early-stage (I–II) cases (p < 0.05), showing strong association with lymph node metastasis, postmenopausal status, and receptor negativity. ROC analysis demonstrated HOTAIR’s predictive potential with an AUC of 0.73 (sensitivity: 64%; specificity: 86%). MALAT1 expression was non-significantly elevated in late-stage tumors. Logistic regression analysis we observed that overexpression of HOTAIR, lymph node involvement, and hormone receptor negativity as increases disease risk. The findings indicate that HOTAIR over expression serves as a potential prognostic biomarker for breast cancer at late stage and associated with clinicopathological features and disease progression.